Journal of Clinical Laboratory Analysis

Papers
(The H4-Index of Journal of Clinical Laboratory Analysis is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
624
Exploration of the Clinical Effect of Different Autotransfusion Methods on Patients With Femoral Shaft Fracture Surgery322
Hsa_circ_0008726 regulates the proliferation, migration, and invasion of trophoblast cells in preeclampsia through modulating the miR‐1290‐LHX6 signaling pathway146
Evaluation of chromosomal abnormalities in the postnatal cohort: A single‐center study on 14,242 patients83
A dilute‐and‐shoot liquid chromatography–tandem mass spectrometry method for urinary 18‐hydroxycortisol quantification and its application in establishing reference intervals62
Diagnostic value of total testosterone and free androgen index measured by LCMS/MS for PCOS and insulin resistance61
Combination of C‐reactive protein, procalcitonin, IL‐6, IL‐8, and IL‐10 for early diagnosis of hyperinflammatory state and organ dysfunction in pediatric sepsis61
Hsa_hsa_circ_0081069 promotes the progression of colorectal cancer through sponging miR‐665 and regulating E2F3 expression51
A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug‐Resistant and Extensively Drug‐Resistant Mycobacterium tuberculosis51
Misdiagnosis of a patient with congenital dysfibrinogenemia: A case report and literature review49
CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis47
Corrigendum46
Issue Information45
Deciphering the Role of Calcium Signaling Pathway‐Associated Single Nucleotide Variants in Susceptibility to Hypertension43
A Large‐Scale Retrospective Study of Serum Des‐Gamma‐Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on Specificity41
Analytical and clinical evaluation of the light‐initiated chemiluminescent assays for measurement of human thyroid hormones40
Aberrant blood MALT1 and its relevance with multiple organic dysfunctions, T helper cells, inflammation, and mortality risk of sepsis patients38
Rapid detection of the irinotecan‐related UGT1A1*28 polymorphism by asymmetric PCR melting curve analysis using one fluorescent probe35
Soluble Triggering Receptors on Myeloid Cells‐1 Could Be a Potential Biomarker for Disease Activity in Familial Mediterranean Fever34
Associations of CYP2B6 genetic polymorphisms with Hirschsprung’s disease in a southern Chinese population34
Performance evaluation of the i‐Smart 300E cartridge for point‐of‐care electrolyte measurement in serum and plasma34
Proxalutamide for the treatment of COVID‐19 rebound following Paxlovid treatment: Report of four cases and review of the literature33
IL‐6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID‐19 patients33
Development of six immune‐related lncRNA signature prognostic model for smoking‐positive lung adenocarcinoma33
hsa_circ_0115355 promotes pancreatic β‐cell function in patients with type 2 diabetes through the miR‐145/SIRT1 axis32
The usefulness of the estimated average glucose/fasting blood glucose ratio for pancreatic β‐cell function assessment in hyperglycemia during health checkups31
Ultra‐Sensitive Quantification of Indoxyl Sulfate and 3‐Carboxy‐4‐Methyl‐5‐Propyl‐2‐Furanpropanoic Acid in Plasma Using Ultra‐Performance Liquid Chromatography Coupled to Quadrupole Time‐of‐Flight Mas31
Circulating tumor necrosis factor‐α, interleukin‐1β, and interleukin‐17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients31
31
CYP2S1 rs338599 polymorphism confers reduced risk to anti‐tuberculosis drug‐induced liver injury and may be a novel marker for its risk prediction31
Validation of high concentrated thrombin time assay for unfractionated heparin monitoring30
Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis30
Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer30
0.093865871429443